Deleted Tweet from , -D.C.
Deleted Tweet from U.S. FDA
We published several guidances focused on generic drug application submissions, labeling, and review. These guidances are part of the FDA’s continued efforts to bring greater efficiency and transparency to the generic drug review process. https://t.co/PbhRuhXRcl
It looks like this tweet was replaced by the next tweet from @US_FDA.